Total Payments
$129,200
2021 Payments
$25,080
Companies
1
Transactions
43
Medicare Patients
20,127
Medicare Billing
$946,471
Payment Breakdown by Category
Consulting$129,200 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $129,200 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $129,200 | 43 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $25,080 | 12 | PFIZER INC. ($25,080) |
| 2020 | $47,515 | 12 | PFIZER INC. ($47,515) |
| 2019 | $47,910 | 12 | PFIZER INC. ($47,910) |
| 2018 | $8,695 | 7 | PFIZER INC. ($8,695) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,950.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,075.00 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,380.00 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,495.00 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,365.00 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,820.00 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,105.00 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,465.00 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $780.00 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: ONCOLOGY | ||||||
| 12/28/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,495.00 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,510.00 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $5,330.00 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $8,455.00 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,210.00 | General |
| Category: ONCOLOGY | ||||||
| 06/15/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,145.00 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $5,150.00 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,555.00 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $5,615.00 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $5,590.00 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2019 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,155.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 4,995 | 10,881 | $1.8M | $239,718 |
| 2022 | 41 | 4,466 | 11,610 | $1.7M | $229,460 |
| 2021 | 54 | 5,779 | 10,441 | $1.8M | $260,630 |
| 2020 | 51 | 4,887 | 6,226 | $1.5M | $216,664 |
Total Patients
20,127
Total Services
39,158
Medicare Billing
$946,471
Procedure Codes
228
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 1,076 | 1,239 | $364,266 | $42,984 | 11.8% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 495 | 507 | $154,128 | $19,991 | 13.0% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2023 | 219 | 225 | $104,625 | $16,217 | 15.5% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2023 | 205 | 212 | $98,580 | $15,772 | 16.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 181 | 186 | $114,390 | $14,674 | 12.8% |
| 72131 | Ct scan of lower spine without contrast | Facility | 2023 | 340 | 347 | $111,040 | $14,000 | 12.6% |
| 72128 | Ct scan of middle spine without contrast | Facility | 2023 | 309 | 314 | $100,480 | $12,685 | 12.6% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 30 | 34 | $101,320 | $9,673 | 9.5% |
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 89 | 94 | $46,248 | $9,101 | 19.7% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 134 | 137 | $57,951 | $8,699 | 15.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 114 | 114 | $61,788 | $8,471 | 13.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 98 | 99 | $46,035 | $7,446 | 16.2% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 27 | 27 | $41,985 | $4,961 | 11.8% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 27 | 27 | $43,425 | $4,535 | 10.4% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 99 | 99 | $27,027 | $4,354 | 16.1% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 120 | 120 | $40,200 | $4,036 | 10.0% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 77 | 78 | $40,404 | $3,755 | 9.3% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 441 | 465 | $19,530 | $3,605 | 18.5% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 50 | 50 | $17,800 | $2,908 | 16.3% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Facility | 2023 | 26 | 28 | $13,776 | $2,733 | 19.8% |
| 70496 | Ct scan of blood vessels of head with contrast | Office | 2023 | 18 | 18 | $16,140 | $2,618 | 16.2% |
| 72141 | Mri scan of upper spinal canal without contrast | Facility | 2023 | 40 | 40 | $14,840 | $2,557 | 17.2% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Facility | 2023 | 27 | 27 | $17,280 | $2,553 | 14.8% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 13 | 13 | $19,890 | $2,231 | 11.2% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 28 | 28 | $18,796 | $2,062 | 11.0% |
About Dr. Lev Bangiyev, DO
Dr. Lev Bangiyev, DO is a Diagnostic Radiology healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215007323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lev Bangiyev, DO has received a total of $129,200 in payments from pharmaceutical and medical device companies, with $25,080 received in 2021. These payments were reported across 43 transactions from 1 company. The most common payment nature is "Consulting Fee" ($129,200).
As a Medicare-enrolled provider, Bangiyev has provided services to 20,127 Medicare beneficiaries, totaling 39,158 services with total Medicare billing of $946,471. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Stony Brook, NY
- Active Since 11/08/2006
- Last Updated 11/29/2013
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1215007323
Products in Payments
- LORBRENA (Drug) $126,980
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Stony Brook
Dr. Kevin Baker, Md, MD
Diagnostic Radiology — Payments: $1.0M
Diagnostic Radiology $1.0M
Michael Reiter, D.o, D.O
Diagnostic Radiology — Payments: $243,806
Diagnostic Radiology $243,806
Dr. Steven West, M.d, M.D
Diagnostic Radiology — Payments: $234,190
Diagnostic Radiology $234,190
Annapurneswara Chimpiri, Md, MD
Diagnostic Radiology — Payments: $30,887
Diagnostic Radiology $30,887
Charles Lugo, M.d, M.D
Diagnostic Radiology — Payments: $22,881
Diagnostic Radiology $22,881
Dr. Vladimir Sheynzon, Md, MD
Diagnostic Radiology — Payments: $11,777
Diagnostic Radiology $11,777